Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

Index by author

May 1, 2024; Volume 65,Issue 5

This Month in JNM

  • You have access
    This Month in JNM
    Journal of Nuclear Medicine May 1, 2024, 65 (5) 10A;

Discussions with Leaders

  • You have access
    Supporting Imaging at the Highest Level
    Janet Eary and Lale Kostakoglu
    Journal of Nuclear Medicine May 1, 2024, 65 (5) 667-669; DOI: https://doi.org/10.2967/jnumed.124.267727

State of the Art

  • You have access
    Quantitative Brain Amyloid PET
    William J. Jagust, Venkata S. Mattay, Daniel M. Krainak, Sue-Jane Wang, Lora D. Weidner, A. Alex Hofling, Hayoung Koo, Pamela Hsieh, Phillip H. Kuo, Gill Farrar and Libero Marzella
    Journal of Nuclear Medicine May 1, 2024, 65 (5) 670-678; DOI: https://doi.org/10.2967/jnumed.123.265766

Continuing Education

  • You have access
    Clinical Management of Advanced Prostate Cancer: Where Does Radiopharmaceutical Therapy Fit in the Treatment Algorithm?
    Paul Viscuse, Michael Devitt and Robert Dreicer
    Journal of Nuclear Medicine May 1, 2024, 65 (5) 679-685; DOI: https://doi.org/10.2967/jnumed.123.267006

Is It Really Happening?

  • You have access
    Is 161Tb Really Happening?
    Grace Kong, James P. Buteau and Michael S. Hofman
    Journal of Nuclear Medicine May 1, 2024, 65 (5) 686-687; DOI: https://doi.org/10.2967/jnumed.124.267611

Oncology

  • Clinical

    • [<sup>18</sup>F]FET PET/MRI: An Accurate Technique for Detection of Small Functional Pituitary Tumors
      You have access
      [18F]FET PET/MRI: An Accurate Technique for Detection of Small Functional Pituitary Tumors
      Ilanah J. Pruis, Frederik A. Verburg, Rutger K. Balvers, Anita A. Harteveld, Richard A. Feelders, Meike W. Vernooij, Marion Smits, Sebastian J.C.M.M. Neggers and Sophie E.M. Veldhuijzen van Zanten
      Journal of Nuclear Medicine May 1, 2024, 65 (5) 688-692; DOI: https://doi.org/10.2967/jnumed.123.266853
    • Cancer Risk in Graves Disease with Radioactive <sup>131</sup>I Treatment: A Nationwide Cohort Study
      You have access
      Cancer Risk in Graves Disease with Radioactive 131I Treatment: A Nationwide Cohort Study
      Kyeong Jin Kim, Jimi Choi, Kyoung Jin Kim, Eyun Song, Ji Hee Yu, Nam Hoon Kim, Hye Jin Yoo, Ji A Seo, Nan Hee Kim, Kyung Mook Choi, Sei Hyun Baik and Sin Gon Kim
      Journal of Nuclear Medicine May 1, 2024, 65 (5) 693-699; DOI: https://doi.org/10.2967/jnumed.123.266531
    • Human Epidermal Growth Factor Receptor 2 (HER2) PET Imaging of HER2-Low Breast Cancer with [<sup>68</sup>Ga]Ga-ABY-025: Results from a Pilot Study
      You have access
      Human Epidermal Growth Factor Receptor 2 (HER2) PET Imaging of HER2-Low Breast Cancer with [68Ga]Ga-ABY-025: Results from a Pilot Study
      Renske Altena, Siri af Burén, August Blomgren, Emelie Karlsson, Antonios Tzortzakakis, Nikolai Brun, Mohammad M. Moein, Emma Jussing, Fredrik Y. Frejd, Jonas Bergh, Thuy A. Tran, Johan Hartman and Rimma Axelsson
      Journal of Nuclear Medicine May 1, 2024, 65 (5) 700-707; DOI: https://doi.org/10.2967/jnumed.123.266847
    • Optimal [<sup>18</sup>F]FDG PET/CT Cutoff for Pathologic Complete Response in HER2-Positive Early Breast Cancer Patients Treated with Neoadjuvant Trastuzumab and Pertuzumab in the PHERGain Trial
      You have access
      Optimal [18F]FDG PET/CT Cutoff for Pathologic Complete Response in HER2-Positive Early Breast Cancer Patients Treated with Neoadjuvant Trastuzumab and Pertuzumab in the PHERGain Trial
      Geraldine Gebhart, Marleen Keyaerts, Thomas Guiot, Patrick Flamen, Manuel Ruiz-Borrego, Agostina Stradella, Begoña Bermejo, Santiago Escriva-de-Romani, Lourdes Calvo Martínez, Nuria Ribelles, María Fernandez-Abad, Cinta Albacar, Marco Colleoni, Laia Garrigos, Manuel Atienza de Frutos, Florence Dalenc, Aleix Prat, Frederik Marmé, Peter Schmid, Khaldoun Kerrou, Sofia Braga, Petra Gener, Miguel Sampayo-Cordero, Javier Cortés, José Manuel Pérez-García and Antonio Llombart-Cussac
      Journal of Nuclear Medicine May 1, 2024, 65 (5) 708-713; DOI: https://doi.org/10.2967/jnumed.123.266384
    • High-Temporal-Resolution Kinetic Modeling of Lung Tumors with Dual-Blood Input Function Using Total-Body Dynamic PET
      You have access
      High-Temporal-Resolution Kinetic Modeling of Lung Tumors with Dual-Blood Input Function Using Total-Body Dynamic PET
      Yiran Wang, Yasser G. Abdelhafez, Benjamin A. Spencer, Rashmi Verma, Mamta Parikh, Nicholas Stollenwerk, Lorenzo Nardo, Terry Jones, Ramsey D. Badawi, Simon R. Cherry and Guobao Wang
      Journal of Nuclear Medicine May 1, 2024, 65 (5) 714-721; DOI: https://doi.org/10.2967/jnumed.123.267036
    • <sup>18</sup>F-BMS-986229 PET to Assess Programmed-Death Ligand 1 Status in Gastroesophageal Cancer
      You have access
      18F-BMS-986229 PET to Assess Programmed-Death Ligand 1 Status in Gastroesophageal Cancer
      Samuel L. Cytryn, Neeta Pandit-Taskar, Melissa A. Lumish, Steven B. Maron, Ping Gu, Geoffrey Y. Ku, Joanne F. Chou, Marinela Capanu, Ariel Antoine, Diane Loegel, Lara Feder, Steven Philemond, Serge K. Lyashchenko, Jason S. Lewis, Viktoriya Paroder, Amitabh Srivastava, Laura H. Tang, Heiko Schoder and Yelena Y. Janjigian
      Journal of Nuclear Medicine May 1, 2024, 65 (5) 722-727; DOI: https://doi.org/10.2967/jnumed.123.267186
  • Basic

    • FEATURED BASIC SCIENCE ARTICLE

      • Noninvasively Deciphering the Immunosuppressive Tumor Microenvironment Using Galectin-1 PET to Inform Immunotherapy Responses
        You have access
        Noninvasively Deciphering the Immunosuppressive Tumor Microenvironment Using Galectin-1 PET to Inform Immunotherapy Responses
        Ning Liu, Xiujie Yang, Chao Gao, Jianze Wang, Yuwen Zeng, Linyu Zhang, Qi Yin, Ting Zhang, Haoyi Zhou, Kui Li, Jinhong Du, Shixin Zhou, Xuyang Zhao, Hua Zhu, Zhi Yang and Zhaofei Liu
        Journal of Nuclear Medicine May 1, 2024, 65 (5) 728-734; DOI: https://doi.org/10.2967/jnumed.123.266888

Theranostics

  • Clinical

    • BRIEF COMMUNICATION

      • Real-World Experience with <sup>177</sup>Lu-PSMA-617 Radioligand Therapy After Food and Drug Administration Approval
        You have access
        Real-World Experience with 177Lu-PSMA-617 Radioligand Therapy After Food and Drug Administration Approval
        Abuzar Moradi Tuchayi, Surekha Yadav, Fei Jiang, Sarasa T. Kim, Rachelle K. Saelee, Amanda Morley, Roxanna Juarez, Courtney Lawhn-Heath, Yingbing Wang, Ivan de Kouchkovsky and Thomas A. Hope
        Journal of Nuclear Medicine May 1, 2024, 65 (5) 735-739; DOI: https://doi.org/10.2967/jnumed.123.266842
    • FEATURED ARTICLE OF THE MONTH

      • First-in-Human Safety, Imaging, and Dosimetry of a Carbonic Anhydrase IX–Targeting Peptide, [<sup>68</sup>Ga]Ga-DPI-4452, in Patients with Clear Cell Renal Cell Carcinoma
        Open Access
        First-in-Human Safety, Imaging, and Dosimetry of a Carbonic Anhydrase IX–Targeting Peptide, [68Ga]Ga-DPI-4452, in Patients with Clear Cell Renal Cell Carcinoma
        Michael S. Hofman, Ben Tran, Darren R. Feldman, Anna Pokorska-Bocci, Solen Pichereau, Jonathan Wessen, Mohammad B. Haskali, Richard B. Sparks, Olena Vlasyuk and Ivana Galetic
        Journal of Nuclear Medicine May 1, 2024, 65 (5) 740-743; DOI: https://doi.org/10.2967/jnumed.123.267175
    • You have access
      Kick-Starting Molecular Theranostics in Renal Cell Carcinoma
      Viktor Grünwald, Boris Hadschik, Niklas Klümper and Ken Herrmann
      Journal of Nuclear Medicine May 1, 2024, 65 (5) 744-745; DOI: https://doi.org/10.2967/jnumed.124.267618
    • Effectiveness and Safety of Retreatment with <sup>177</sup>Lu-DOTATATE in Patients with Progressive Neuroendocrine Tumors: A Retrospective Real-World Study in the United States
      You have access
      Effectiveness and Safety of Retreatment with 177Lu-DOTATATE in Patients with Progressive Neuroendocrine Tumors: A Retrospective Real-World Study in the United States
      Ebrahim S. Delpassand, Soheil M. Yazdi, Shashank Ghantoji, Antonio Nakasato, Corinne Strickland, Rodolfo Nunez, Afshin Shafie, Susan Cork, Clare Byrne, Jackson Tang and Jeetvan Patel
      Journal of Nuclear Medicine May 1, 2024, 65 (5) 746-752; DOI: https://doi.org/10.2967/jnumed.123.265703
    • SPECT/CT Image-Derived Absorbed Dose to Red Marrow Correlates with Hematologic Toxicity in Patients Treated with [<sup>177</sup>Lu]Lu-DOTATATE
      You have access
      SPECT/CT Image-Derived Absorbed Dose to Red Marrow Correlates with Hematologic Toxicity in Patients Treated with [177Lu]Lu-DOTATATE
      Johan Blakkisrud, Avery B. Peterson, Scott J. Wildermann, Griffen Kingkiner, Ka Kit Wong, Chang Wang, Kirk A. Frey, Caroline Stokke and Yuni K. Dewaraja
      Journal of Nuclear Medicine May 1, 2024, 65 (5) 753-760; DOI: https://doi.org/10.2967/jnumed.123.266843
  • Basic

    • Preclinical Characterization of DPI-4452: A <sup>68</sup>Ga/<sup>177</sup>Lu Theranostic Ligand for Carbonic Anhydrase IX
      Open Access
      Preclinical Characterization of DPI-4452: A 68Ga/177Lu Theranostic Ligand for Carbonic Anhydrase IX
      Frédéric Massière, Norbert Wiedemann, Inês Borrego, Aileen Hoehne, Frank Osterkamp, Matthias Paschke, Dirk Zboralski, Anne Schumann, Anne Bredenbeck, Franck Brichory and Antoine Attinger
      Journal of Nuclear Medicine May 1, 2024, 65 (5) 761-767; DOI: https://doi.org/10.2967/jnumed.123.266309

Cardiovascular

  • Clinical

    • Artificial Intelligence Predicts Hospitalization for Acute Heart Failure Exacerbation in Patients Undergoing Myocardial Perfusion Imaging
      You have access
      Artificial Intelligence Predicts Hospitalization for Acute Heart Failure Exacerbation in Patients Undergoing Myocardial Perfusion Imaging
      Attila Feher, Bryan Bednarski, Robert J. Miller, Aakash Shanbhag, Mark Lemley, Leonidas Miras, Albert J. Sinusas, Edward J. Miller and Piotr J. Slomka
      Journal of Nuclear Medicine May 1, 2024, 65 (5) 768-774; DOI: https://doi.org/10.2967/jnumed.123.266761
  • Basic

    • Development of a CD163-Targeted PET Radiotracer That Images Resident Macrophages in Atherosclerosis
      You have access
      Development of a CD163-Targeted PET Radiotracer That Images Resident Macrophages in Atherosclerosis
      Xiuli Zhang, Gyu Seong Heo, Alexandria Li, Divangana Lahad, Lisa Detering, Joan Tao, Xuefeng Gao, Xiaohui Zhang, Hannah Luehmann, Deborah Sultan, Lanlan Lou, Rajiu Venkatesan, Ran Li, Jie Zheng, Junedh Amrute, Chieh-Yu Lin, Benjamin J. Kopecky, Robert J. Gropler, Andrea Bredemeyer, Kory Lavine and Yongjian Liu
      Journal of Nuclear Medicine May 1, 2024, 65 (5) 775-780; DOI: https://doi.org/10.2967/jnumed.123.266910

Neurology

  • Clinical

    • Impact of PET Reconstruction on Amyloid-β Quantitation in Cross-Sectional and Longitudinal Analyses
      Open Access
      Impact of PET Reconstruction on Amyloid-β Quantitation in Cross-Sectional and Longitudinal Analyses
      Gihan P. Ruwanpathirana, Robert C. Williams, Colin L. Masters, Christopher C. Rowe, Leigh A. Johnston and Catherine E. Davey
      Journal of Nuclear Medicine May 1, 2024, 65 (5) 781-787; DOI: https://doi.org/10.2967/jnumed.123.266188
  • Basic

    • Robust Quantification of Phosphodiesterase-4D in Monkey Brain with PET and <sup>11</sup>C-Labeled Radioligands That Avoid Radiometabolite Contamination
      You have access
      Robust Quantification of Phosphodiesterase-4D in Monkey Brain with PET and 11C-Labeled Radioligands That Avoid Radiometabolite Contamination
      Meijuan Jiang, Shiyu Tang, Madeline D. Jenkins, Adrian C. Lee, Bruny Kenou, Carson Knoer, Jose Montero Santamaria, Shawn Wu, Jeih-San Liow, Sami S. Zoghbi, Paolo Zanotti-Fregonara, Robert B. Innis, Sanjay Telu and Victor W. Pike
      Journal of Nuclear Medicine May 1, 2024, 65 (5) 788-793; DOI: https://doi.org/10.2967/jnumed.123.266750

Radiobiology/Dosimetry

  • Basic

    • You have access
      MIRD Pamphlet No. 29: MIRDy90—A 90Y Research Microsphere Dosimetry Tool
      Harry Marquis, Juan C. Ocampo Ramos, Lukas M. Carter, Pat Zanzonico, Wesley E. Bolch, Richard Laforest and Adam L. Kesner
      Journal of Nuclear Medicine May 1, 2024, 65 (5) 794-802; DOI: https://doi.org/10.2967/jnumed.123.266743

AI/Advanced Image Analysis

  • Basic

    • Impact of <sup>18</sup>F-FDG PET Intensity Normalization on Radiomic Features of Oropharyngeal Squamous Cell Carcinomas and Machine Learning–Generated Biomarkers
      You have access
      Impact of 18F-FDG PET Intensity Normalization on Radiomic Features of Oropharyngeal Squamous Cell Carcinomas and Machine Learning–Generated Biomarkers
      Stefan P. Haider, Tal Zeevi, Kariem Sharaf, Moritz Gross, Amit Mahajan, Benjamin H. Kann, Benjamin L. Judson, Manju L. Prasad, Barbara Burtness, Mariam Aboian, Martin Canis, Christoph A. Reichel, Philipp Baumeister and Seyedmehdi Payabvash
      Journal of Nuclear Medicine May 1, 2024, 65 (5) 803-809; DOI: https://doi.org/10.2967/jnumed.123.266637
    • ISIT-QA: In Silico Imaging Trial to Evaluate a Low-Count Quantitative SPECT Method Across Multiple Scanner–Collimator Configurations for <sup>223</sup>Ra-Based Radiopharmaceutical Therapies
      Open Access
      ISIT-QA: In Silico Imaging Trial to Evaluate a Low-Count Quantitative SPECT Method Across Multiple Scanner–Collimator Configurations for 223Ra-Based Radiopharmaceutical Therapies
      Zekun Li, Nadia Benabdallah, Jingqin Luo, Richard L. Wahl, Daniel L.J. Thorek and Abhinav K. Jha
      Journal of Nuclear Medicine May 1, 2024, 65 (5) 810-817; DOI: https://doi.org/10.2967/jnumed.123.266719

The Illustrated Post

  • You have access
    PSMA PET/CT Dual-Time-Point Imaging: Nice to Have or Need to Have?
    Lena M. Unterrainer, Kathleen Ruchalski, Martin S. Allen-Auerbach, Jeremie Calais and Matthias R. Benz
    Journal of Nuclear Medicine May 1, 2024, 65 (5) 818-819; DOI: https://doi.org/10.2967/jnumed.123.266722

The Illustrated Post

  • You have access
    [68Ga]Ga-FAPI-46 PET in a Borderline Ovarian Tumor
    Lena M. Unterrainer, Sanaz Memarzadeh, Neda A. Moatamed, Matthias R. Benz, Johannes Czernin and Jeremie Calais
    Journal of Nuclear Medicine May 1, 2024, 65 (5) 820-821; DOI: https://doi.org/10.2967/jnumed.123.266732

Letters to the Editor

  • You have access
    64Cu-DOTA Enables Late PET Imaging and Leak Detection in the Cerebrospinal Fluid Space
    Robert Drescher, Julia Greiser, Sebastian Gröber, Thomas Weisheit and Martin Freesmeyer
    Journal of Nuclear Medicine May 1, 2024, 65 (5) 822; DOI: https://doi.org/10.2967/jnumed.123.267329

In Memoriam

  • You have access
    Gerald L. DeNardo, MD, 1932–2024
    Journal of Nuclear Medicine May 1, 2024, 65 (5) 823; DOI: https://doi.org/10.2967/jnumed.124.267679

Departments

  • You have access
    Errata
    Journal of Nuclear Medicine May 1, 2024, 65 (5) 809;
Back to top
PreviousNext

In this issue

Journal of Nuclear Medicine: 65 (5)
Journal of Nuclear Medicine
Vol. 65, Issue 5
May 1, 2024
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Complete Issue (PDF)

Issue highlights

  • First-in-Human Safety, Imaging, and Dosimetry of a Carbonic Anhydrase IX–Targeting Peptide, [68Ga]Ga-DPI-4452, in Patients with Clear Cell Renal Cell Carcinoma
  • Noninvasively Deciphering the Immunosuppressive Tumor Microenvironment Using Galectin-1 PET to Inform Immunotherapy Responses
Sign up for alerts

Jump to

  • This Month in JNM
  • Discussions with Leaders
  • State of the Art
  • Continuing Education
  • Is It Really Happening?
  • Oncology
    • Clinical
    • Basic
      • FEATURED BASIC SCIENCE ARTICLE
  • Theranostics
    • Clinical
      • BRIEF COMMUNICATION
      • FEATURED ARTICLE OF THE MONTH
    • Basic
  • Cardiovascular
    • Clinical
    • Basic
  • Neurology
    • Clinical
    • Basic
  • Radiobiology/Dosimetry
    • Basic
  • AI/Advanced Image Analysis
    • Basic
  • The Illustrated Post
  • The Illustrated Post
  • Letters to the Editor
  • In Memoriam
  • Departments
  • Most Cited
  • Most Read
Loading
  • MIRD Pamphlet No. 28, Part 1: MIRDcalc—A Software Tool for Medical Internal Radiation Dosimetry
  • Absorbed Dose–Response Relationship in Patients with Gastroenteropancreatic Neuroendocrine Tumors Treated with [177Lu]Lu-DOTATATE: One Step Closer to Personalized Medicine
  • Prediction of 177Lu-DOTATATE PRRT Outcome Using Multimodality Imaging in Patients with Gastroenteropancreatic Neuroendocrine Tumors: Results from a Prospective Phase II LUMEN Study
  • Renal and Multiorgan Safety of 177Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer in the VISION Dosimetry Substudy
  • High-Temporal-Resolution Lung Kinetic Modeling Using Total-Body Dynamic PET with Time-Delay and Dispersion Corrections
More...
SNMMI

© 2025 SNMMI

Powered by HighWire